Navigation Links
Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
Date:3/18/2009

SAN FRANCISCO, March 18 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it has received written permission from the U.S. Food and Drug Administration (FDA) to begin a pivotal Phase 3 trial of MDV3100, its novel androgen receptor antagonist, in patients with metastatic castration-resistant prostate cancer (CRPC) who have failed docetaxel-based chemotherapy. The placebo-controlled, double-blind, multinational trial will enroll approximately 1,200 patients who will be randomized (2:1) to receive either MDV3100 or placebo. The primary endpoint of the trial will be overall survival.

"This is a significant milestone in the development of this important novel investigational drug," said David T. Hung, M.D., president and chief executive officer of Medivation. "We look forward to starting the trial and rapidly executing a comprehensive Phase 3 development program for MDV3100. Given the encouraging results seen to date in our ongoing Phase 1-2 trial and the limited life expectancy of men with CRPC who have failed chemotherapy, we will work to begin the Phase 3 clinical development of MDV3100 as quickly as possible this year."

The FDA informed the Company that it could test a dose of MDV3100 up to 240mg/day. There are no driving or other restrictions placed on the activities of participants in the trial. Final trial specifics will be announced when the first patient is enrolled.

MDV3100 Ongoing Phase 1-2 Trial

MDV3100 is being evaluated in an ongoing open-label, U.S., Phase 1-2 study of a total of 140 men with CRPC. Patients in this trial were heavily pretreated, with all having failed standard hormonal therapies and many having also failed docetaxel-based chemotherapy. MDV3100 has consistently demonstrated encouraging anti-tumor activity across dose levels and endpoints
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
2. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
3. Medivation Announces Participation in Upcoming Conferences
4. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
5. Medivation Announces Participation in Upcoming Conferences
6. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
7. Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimers Disease in Second Quarter of 2008
8. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
9. Urban Health Plan Receives $1.3M from Economic Stimulus Package to Increase Health Care Access in Corona, Queens
10. CUREXO Technology Corporation Receives Quality Certificate
11. Silk Information Systemss Silk V 4.2 Receives 08 CCHIT Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... CA (PRWEB) June 19, 2013 Brain ... DHSc, DC, MS, explains why such seemingly minor brain ... or concussions are vital red flags. They indicate the ... for multiple sclerosis (MS), Alzheimer’s, Parkinson’s, stroke, and other ... released in June 2013 by Elephant Press is now ...
(Date:6/19/2013)... June 19, 2013 Kleritec, Inc. announced ... located at http://www.kleritec.com . In the recent expansion ... art and activities packages for pre-school and day care ... a method to aid teachers across the United States ... in learning. , Included in the art and activities ...
(Date:6/19/2013)... City, UT (PRWEB) June 19, 2013 ... : , In July 2013, Orriant is launching ... participation rates, and maintain compliance with regulations. ... employees to receive wellness incentives if their employer ... announced they have been compliant with these standards ...
(Date:6/19/2013)... TX (PRWEB) June 19, 2013 Chrysler made ... concerning a recall of 2.7 million Jeeps. The Jeep models ... 2002-2007 Jeep Liberty, which according to the NHTSA are vulnerable ... gas tanks in these models are rear-mounted and have been ... agency findings show the Grand Cherokee with 32 rear-end crashes, ...
(Date:6/19/2013)... City, Utah (PRWEB) June 19, 2013 ... Wisconsin Health Insurance Exchange . Zane Benefits, which ... health benefits, is the leader in defined contribution ... According to Zane Benefits’ website, as part of the ... and small businesses will become available through new state ...
Breaking Medicine News(10 mins):Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:Kleritec Announces Addition of Educational Products. 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 3Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3
... 54 Dead and 105 Wounded in Recent Teen ... On February 14,Illinois gunman Steven Kazmierczak became ... influence of psychiatric drugs documented by international,drug regulatory ... in the case of one antidepressant, "homicidal,ideation." With ...
... How Allergies Take a Toll on Americans, Personal and ... Professional Lives ... of,spring only 15 days away, actress and entertainer Molly Shannon is teaming,with ... No Laughing Matter educational campaign. Molly and AAFA, with,support from the makers ...
... introduced at all NHS Hospital Trusts a study by researchers ... still prevalent, even by staff in uniform. , Researchers in ... is critical and more must be done to find better ... nicotine withdrawal and stop smoking on site. , The ...
... Clinical Research Associate at Kendle ... International, Inc., Joins Catalyst, CORAL GABLES, Fla., ... today announced the,appointment of Patrick Kenny as Director - Corporate ... ensuring the,effectiveness and GCP compliance of the CROs, clinical contractors ...
... Management Services Corporation,(ADAMS), the leading provider of program ... the addition of Deborah (Debbie) J.,Aiken and Brandon ... and Mr.,Cannaday have joined ADAMS as Associate Project ... and are both based out of ADAMS,Cleveland, Ohio ...
... -Multimedia Capabilities of the Dynamic LearnSpace, Such as eLocker, Chat ... and Online Testing, To ... Studywiz Spark, the first,and only Dynamic LearnSpace for K-12 education, ... Association for Computer,Users in Learning (MACUL) Conference, March 5-7, at ...
Cached Medicine News:Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 2Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 3Health News:Have the Last Laugh on Allergies This Season: Actress Molly Shannon Teams with The Allergy Foundation to Talk About Allergies 2Health News:Have the Last Laugh on Allergies This Season: Actress Molly Shannon Teams with The Allergy Foundation to Talk About Allergies 3Health News:Have the Last Laugh on Allergies This Season: Actress Molly Shannon Teams with The Allergy Foundation to Talk About Allergies 4Health News:Hospitals still not smoke-free 2Health News:Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance 2Health News:Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance 3Health News:Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance 4Health News:ADAMS Welcomes Debbie Aiken and Brandon Cannaday to the Firm's Staff as Associate Project Managers 2Health News:ADAMS Welcomes Debbie Aiken and Brandon Cannaday to the Firm's Staff as Associate Project Managers 3Health News:Southgate Community Schools To Present Studywiz Spark at Michigan Computer Users in Learning (MACUL) Conference 2Health News:Southgate Community Schools To Present Studywiz Spark at Michigan Computer Users in Learning (MACUL) Conference 3
(Date:6/19/2013)... , June 19, 2013  Haemonetics Corporation (NYSE: ... developments in the pursuit of its previously announced ... ) , Haemonetics has selected ... the future production of medical devices currently manufactured ... a leading global provider of integrated manufacturing solutions, ...
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- Robert M. Bernstein, M.D., ... procedures and founder of Bernstein Medical – Center ... Doctors, issue of New York Magazine for the ... ) Dr. Bernstein earned his ... reputation as world-renowned hair restoration physician, through a ...
(Date:6/19/2013)... 2013 Dr. Davis Lee , CMIO ... recipients of the 2013 AMDIS Award, a prestigious recognition ... "On behalf of Allscripts, I,d like ... innovation and continuous efforts to improve patient care and ... and Chief Executive Officer of Allscripts. "We are committed ...
Breaking Medicine Technology:Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5
... MedSolutions , a leading provider ... its Lumbar Spine Surgery Management Program for ensuring the ... lower back pain, spinal stenosis, spondylolisthesis, scoliosis, trauma, infections ... been estimated that up to 80 percent of the ...
... Mettler-Toledo International Inc. (NYSE: MTD ) today ... Company,s second-quarter results on Thursday, July 28, 2011 at 5:00 ... call, visit www.mt.com/investors on the Company,s website. A ... 2011. METTLER TOLEDO is a leading global ...
Cached Medicine Technology:MedSolutions Introduces Spine Surgery Management Program 2MedSolutions Introduces Spine Surgery Management Program 3
... Ossur range of prefabricated foot and ankle ... - from ankle instability to foot malalignment. ... designs and energy-return technology., ,Age is ... ankle foot orthoses provide a measure of ...
... The Stabilizing Ankle support features ... which lock the calcaneus into ... eversion and inversion. The full-circumference ... and stability. Ideal for chronic ...
... Walker Pediatric Boot is the ... boot that offers superior comfort ... two sizes are offered thus ... will fit left or right, ...
... The Bledsoe PTB Boot is ... alternative to casting for the mid-tibia ... providing patella tendon bearing support. The ... designed for range of motion from ...
Medicine Products: